Caplin Point Laboratories Reports Record Financial Results, Indicating Strong Growth Potential

May 15 2025 03:32 PM IST
share
Share Via
Caplin Point Laboratories has announced its financial results for the quarter ending March 2025, achieving record quarterly net sales of Rs 502.45 crore and a Profit After Tax of Rs 142.57 crore. The company also reported its highest Operating Profit and Earnings per Share, indicating strong financial performance.
Caplin Point Laboratories, a midcap player in the Pharmaceuticals & Biotechnology sector, has reported its financial results for the quarter ending March 2025. The results, declared on May 15, 2025, indicate a notable shift in the company's evaluation, with its score adjusting to 8 from 7 over the past three months.

The financial data reveals that Caplin Point Laboratories achieved its highest quarterly net sales at Rs 502.45 crore, marking a consistent upward trend over the last five quarters. Similarly, the Profit After Tax (PAT) reached Rs 142.57 crore, also the highest in this timeframe, reflecting a strong performance in profitability. The Operating Profit (PBDIT) stood at Rs 168.06 crore, again the highest recorded in the last five quarters, showcasing effective operational management. Additionally, the Profit Before Tax less Other Income (PBT) was reported at Rs 150.93 crore, indicating a positive trajectory in earnings. The Earnings per Share (EPS) reached Rs 18.76, further highlighting the company's ability to generate higher returns for its shareholders.

These developments suggest a robust financial standing for Caplin Point Laboratories, with various metrics showing positive trends.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News